Magazine Article | March 7, 2018

The Dynamics And Value Of Cross-Border Biotech

Source: Life Science Leader

By Jonathan Gertler

The Nordic region has the right ingredients for advancing biotechnology: strong academic and technology communities, seasoned management in both international pharma and local entrepreneurial efforts, and a growing capital base. As biotechnology globalizes, the strategies and tactics these countries and companies need are no different than the approaches made by developing and established companies in Boston and San Francisco.

Last fall, global biotech leaders came together at a life sciences symposium in Copenhagen to share their insights on cross-border development and to discuss the creation of sustainable and independent companies based in a vibrant — but smaller — biotechnology cluster.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: